Shape-shifting drug hits tumors in multiple ways, improves outcomes in mice

Modern anticancer medications that combine tumor-fighting drugs with proteins that specifically target cancer cells are a relatively new class of drugs, often given to patients for whom standard chemotherapy has not worked.

The drugs are precise but can attack only one type of target in a cancer cell at a time.

This limits their effectiveness against tumors containing multiple types of targets, which becomes more likely as cancer progresses or tumors become resistant to conventional therapies. ...